TP53 and neoplasm: Given the therapeutic implications and tumor surveillance, we recommend using chromosome 11p15 molecular assays in routine clinical work-up of patients with pediatric adrenocortical tumors, particularly those with wild type TP53 sequence, with genetic predisposition evaluation and counseling.